Draft NIH Policy Promotes Use of Single IRB for Multi-Site Studies

  • Jan 2015

On December 3, the National Institutes of Health (NIH) announced a draft policy for the “Use of a Single Institutional Review Board (IRB) for Multi-Site Research.” The new policy establishes the expectation that multi-site NIH-funded domestic studies will make use of a single IRB of record, rather than multiple local IRBs. Comments on the proposed policy will be collected by the NIH until January 29, 2015.

The Endocrine Society has consistently advocated for the use of single IRBs for multi-site studies in an effort to increase efficiencies while maintaining high standards for the protection of human research subjects. The Society is enthusiastic about the proposed policy and will develop comments to ensure that the final policy remains broadly consistent with the Endocrine Society’s position statement on Central Institutional Review Boards.

— Joe Laakso is associate director, Science Policy, for the Endocrine Society. For more information, go to: www.nih.gov/about/reporting-preclinical-research.htm.

You may also like

  • Endocrine Society Advocacy Update – March 2024

    Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before…

  • Advocacy Update: February 2024

    Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs…

Find more in